Skip to main content
Terug
Watch Compare

ARTELO BIOSCIENCES, INC.

Datakwaliteit: 83%
ARTL
NASDAQ Manufacturing Chemicals
€ 5,31
▼ € 0,10 (-1,85%)
6 months return
—
Momentum
Neutral
Free cash flow
-8,52 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio0,38
Interest Coverage-58,78

Waardering

PE (TTM)
-0,41
Boven sectorgemiddelde (-1,50)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -8,52 M

Price History

Financiële Trends

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstverassingen

EPS
Reported Estimate Forecast
Next: Q2 2026 · Rev Est: 0,0
Q12025 Q22025 Q32025 Q42025 Q2 '26
Reported -€ 12,96 -€ 16,83 -€ 11,91 -€ 0,12 —
Estimate -€ 2,34 -€ 12,57 — -€ 4,71 —
Verrassing -453,85% -33,89% — +97,45% —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: N/A · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -12,88 M
ROE N/A ROA -298,68%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -8,52 M
ROIC N/A FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 0,38
Debt / Equity N/A Current Ratio 0,38
Interest Coverage -58,78 Asset Turnover N/A
Working Capital -3,03 M Tangible Book Value -2,67 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0,41 · EV/EBITDA: N/A
P/E Ratio -0,41 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -160,17%
Market Cap 5,32 M Enterprise Value 5,32 M

Per Share

EPS: -12,52 · FCF/Share: -10,43
EPS (Diluted TTM) -12,52 Revenue / Share N/A
FCF / Share -10,43 OCF / Share -10,43
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 66,15% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 66,15%
SBC-Adj. FCF -9,50 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -12,88 M -9,83 M -9,29 M -10,08 M -7,44 M
EPS (Diluted) -12,52 -3,05 — — —
Gross Profit — — — — —
Operating Income -11,40 M -10,11 M -9,93 M -10,29 M -7,44 M
EBITDA — — — — —
R&D Expenses 5,42 M 5,99 M 5,70 M 4,32 M 2,84 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 194.000,0 — 0,0 5.000,0 —
Income Tax 0,0 0,0 0,0 0,0 —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2,80 M 4,70 M 13,04 M 20,42 M 12,64 M
Total Liabilities 4,07 M 1,84 M 1,29 M 1,02 M 593.000,0
Shareholders' Equity -1,27 M 2,86 M 11,75 M 19,40 M 12,04 M
Total Debt — — — — —
Cash & Equivalents 600.000,0 — — 6,89 M 6,63 M
Current Assets 695.000,0 2,56 M 10,98 M 18,32 M 10,32 M
Current Liabilities 4,04 M 1,77 M 1,29 M 998.000,0 526.000,0

Sectorvergelijking

vs Manufacturing sector mediaan (1605 peers)
Metriek Aandeel Sector Mediaan
P/E -0,4 -1,5
P/B — 1,6
ROE % — -54,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,7
D/E — 0,3